chr7-754834-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_017802.4(DNAAF5):​c.1257+13A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.833 in 1,578,238 control chromosomes in the GnomAD database, including 548,324 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.83 ( 52691 hom., cov: 33)
Exomes 𝑓: 0.83 ( 495633 hom. )

Consequence

DNAAF5
NM_017802.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.79

Publications

7 publications found
Variant links:
Genes affected
DNAAF5 (HGNC:26013): (dynein axonemal assembly factor 5) The protein encoded by this gene is essential for the preassembly or stability of axonemal dynein arms, and is found only in organisms with motile cilia and flagella. Mutations in this gene are associated with primary ciliary dyskinesia-18, a disorder characterized by abnormalities of motile cilia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2013]
DNAAF5 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 18
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 7-754834-A-G is Benign according to our data. Variant chr7-754834-A-G is described in ClinVar as Benign. ClinVar VariationId is 260922.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.876 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF5NM_017802.4 linkc.1257+13A>G intron_variant Intron 5 of 12 ENST00000297440.11 NP_060272.3 Q86Y56-1B3KPE2
DNAAF5NR_075098.2 linkn.1217+13A>G intron_variant Intron 5 of 12
DNAAF5XM_024446813.2 linkc.1257+13A>G intron_variant Intron 5 of 11 XP_024302581.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF5ENST00000297440.11 linkc.1257+13A>G intron_variant Intron 5 of 12 1 NM_017802.4 ENSP00000297440.6 Q86Y56-1
DNAAF5ENST00000440747.5 linkc.660+13A>G intron_variant Intron 5 of 12 2 ENSP00000403165.1 H0Y650
DNAAF5ENST00000437419.5 linkc.573+13A>G intron_variant Intron 4 of 4 5 ENSP00000410788.1 H7C3B1

Frequencies

GnomAD3 genomes
AF:
0.831
AC:
126419
AN:
152050
Hom.:
52638
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.845
Gnomad AMI
AF:
0.758
Gnomad AMR
AF:
0.824
Gnomad ASJ
AF:
0.848
Gnomad EAS
AF:
0.741
Gnomad SAS
AF:
0.898
Gnomad FIN
AF:
0.799
Gnomad MID
AF:
0.870
Gnomad NFE
AF:
0.831
Gnomad OTH
AF:
0.859
GnomAD2 exomes
AF:
0.820
AC:
184047
AN:
224422
AF XY:
0.828
show subpopulations
Gnomad AFR exome
AF:
0.847
Gnomad AMR exome
AF:
0.728
Gnomad ASJ exome
AF:
0.862
Gnomad EAS exome
AF:
0.762
Gnomad FIN exome
AF:
0.797
Gnomad NFE exome
AF:
0.835
Gnomad OTH exome
AF:
0.838
GnomAD4 exome
AF:
0.833
AC:
1187732
AN:
1426070
Hom.:
495633
Cov.:
27
AF XY:
0.835
AC XY:
589432
AN XY:
705930
show subpopulations
African (AFR)
AF:
0.855
AC:
28114
AN:
32878
American (AMR)
AF:
0.741
AC:
31191
AN:
42104
Ashkenazi Jewish (ASJ)
AF:
0.859
AC:
21529
AN:
25074
East Asian (EAS)
AF:
0.725
AC:
28156
AN:
38810
South Asian (SAS)
AF:
0.895
AC:
75271
AN:
84108
European-Finnish (FIN)
AF:
0.799
AC:
41118
AN:
51476
Middle Eastern (MID)
AF:
0.889
AC:
4544
AN:
5112
European-Non Finnish (NFE)
AF:
0.836
AC:
908824
AN:
1087630
Other (OTH)
AF:
0.832
AC:
48985
AN:
58878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
10178
20357
30535
40714
50892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20830
41660
62490
83320
104150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.831
AC:
126526
AN:
152168
Hom.:
52691
Cov.:
33
AF XY:
0.831
AC XY:
61823
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.846
AC:
35109
AN:
41520
American (AMR)
AF:
0.824
AC:
12602
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.848
AC:
2943
AN:
3472
East Asian (EAS)
AF:
0.741
AC:
3809
AN:
5140
South Asian (SAS)
AF:
0.898
AC:
4326
AN:
4818
European-Finnish (FIN)
AF:
0.799
AC:
8456
AN:
10588
Middle Eastern (MID)
AF:
0.881
AC:
259
AN:
294
European-Non Finnish (NFE)
AF:
0.831
AC:
56510
AN:
68010
Other (OTH)
AF:
0.861
AC:
1821
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1129
2258
3386
4515
5644
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
888
1776
2664
3552
4440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.830
Hom.:
17238
Bravo
AF:
0.833
Asia WGS
AF:
0.840
AC:
2920
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Primary ciliary dyskinesia 18 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.18
DANN
Benign
0.14
PhyloP100
-3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=11/89
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34761279; hg19: chr7-794471; API